Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect

R G Haller, K G Henriksson, L Jorfeldt, E Hultman, R Wibom, K Sahlin, N H Areskog, M Gunder, K Ayyad, C G Blomqvist, R G Haller, K G Henriksson, L Jorfeldt, E Hultman, R Wibom, K Sahlin, N H Areskog, M Gunder, K Ayyad, C G Blomqvist

Abstract

We evaluated a 22-yr-old Swedish man with lifelong exercise intolerance marked by premature exertional muscle fatigue, dyspnea, and cardiac palpitations with superimposed episodes lasting days to weeks of increased muscle fatigability and weakness associated with painful muscle swelling and pigmenturia. Cycle exercise testing revealed low maximal oxygen uptake (12 ml/min per kg; healthy sedentary men = 39 +/- 5) with exaggerated increases in venous lactate and pyruvate in relation to oxygen uptake (VO2) but low lactate/pyruvate ratios in maximal exercise. The severe oxidative limitation was characterized by impaired muscle oxygen extraction indicated by subnormal systemic arteriovenous oxygen difference (a-v O2 diff) in maximal exercise (patient = 4.0 ml/dl, normal men = 16.7 +/- 2.1) despite normal oxygen carrying capacity and Hgb-O2 P50. In contrast maximal oxygen delivery (cardiac output, Q) was high compared to sedentary healthy men (Qmax, patient = 303 ml/min per kg, normal men 238 +/- 36) and the slope of increase in Q relative to VO2 (i.e., delta Q/delta VO2) from rest to exercise was exaggerated (delta Q/delta VO2, patient = 29, normal men = 4.7 +/- 0.6) indicating uncoupling of the normal approximately 1:1 relationship between oxygen delivery and utilization in dynamic exercise. Studies of isolated skeletal muscle mitochondria in our patient revealed markedly impaired succinate oxidation with normal glutamate oxidation implying a metabolic defect at the level of complex II of the mitochondrial respiratory chain. A defect in Complex II in skeletal muscle was confirmed by the finding of deficiency of succinate dehydrogenase as determined histochemically and biochemically. Immunoblot analysis showed low amounts of the 30-kD (iron-sulfur) and 13.5-kD proteins with near normal levels of the 70-kD protein of complex II. Deficiency of succinate dehydrogenase was associated with decreased levels of mitochondrial aconitase assessed enzymatically and immunologically whereas activities of other tricarboxylic acid cycle enzymes were increased compared to normal subjects. The exercise findings are consistent with the hypothesis that this defect impairs muscle oxidative metabolism by limiting the rate of NADH production by the tricarboxylic acid cycle.

References

    1. J Neurol Sci. 1981 Apr;50(1):1-13
    1. Biochim Biophys Acta. 1982 Feb 17;679(2):210-20
    1. Muscle Nerve. 1979 Sep-Oct;2(5):340-8
    1. Biochem Med. 1978 Jun;19(3):366-73
    1. Brain. 1977 Dec;100(4):617-40
    1. Aviat Space Environ Med. 1977 Mar;48(3):203-9
    1. Biochem Med. 1972 Apr;6(2):116-26
    1. Biochemistry. 1975 Jun 17;14(12):2581-8
    1. J Clin Invest. 1973 Dec;52(12):3115-28
    1. Arch Biochem Biophys. 1968 Jul;126(1):75-82
    1. Nature. 1970 Aug 15;227(5259):680-5
    1. Acta Med Scand. 1969 Mar;185(3):153-66
    1. J Biol Chem. 1967 Apr 25;242(8):1870-9
    1. J Cell Biol. 1967 Feb;32(2):415-38
    1. J Neurol Neurosurg Psychiatry. 1964 Oct;27:361-80
    1. Biochem J. 1954 Dec;58(4):685-92
    1. J Biol Chem. 1951 Nov;193(1):265-75
    1. Medicine (Baltimore). 1989 May;68(3):163-72
    1. J Appl Physiol (1985). 1987 Jun;62(6):2442-6
    1. Eur J Pediatr. 1988 May;147(4):418-21
    1. J Appl Physiol (1985). 1988 Aug;65(2):509-18
    1. Brain. 1986 Oct;109 ( Pt 5):915-38
    1. Annu Rev Biochem. 1985;54:1015-69
    1. Clin Chim Acta. 1985 Nov 29;153(1):23-36
    1. J Clin Invest. 1987 Feb;79(2):463-7
    1. Biochem Biophys Res Commun. 1989 Sep 15;163(2):695-700
    1. J Clin Invest. 1989 Jul;84(1):155-61
    1. Pediatr Res. 1989 Feb;25(2):194-201
    1. Anal Biochem. 1989 Dec;183(2):250-7
    1. Exerc Sport Sci Rev. 1989;17:67-113
    1. Neurol Clin. 1989 Feb;7(1):123-56
    1. Neurology. 1989 May;39(5):693-6
    1. Pediatr Res. 1984 Oct;18(10):991-9
    1. Eur J Pediatr. 1984 Nov;143(1):67-71
    1. Brain. 1984 Dec;107 ( Pt 4):1165-77
    1. J Appl Physiol (1985). 1986 Aug;61(2):391-401
    1. N Engl J Med. 1990 Jul 5;323(1):37-42
    1. FASEB J. 1990 May;4(8):2483-91
    1. J Intern Med. 1990 Jul;228(1):43-52
    1. Am J Physiol. 1982 Aug;243(2):H159-69
    1. Eur J Pediatr. 1983 Sep;140(4):332-7
    1. Neurology. 1984 Jan;34(1):48-53
    1. J Clin Invest. 1984 Sep;74(3):685-97
    1. Neurology. 1983 Oct;33(10):1283-7
    1. Clin Pharmacol Ther. 1983 Jun;33(6):701-9
    1. Acta Med Scand. 1979;206(4):309-14

Source: PubMed

3
구독하다